Main > ONCOLOGY (**) > Endometrial Cancer > TREAT.: > JP. E. Lenvatinib+PembrolizuMAb > (*) JP Approval Date: 2021. 12.27

---

(*) JP Approval Date: 2021. 12.27's products
This section has no products